Literature DB >> 20059798

Deinstitutionalization revisited: a 5-year follow-up of a randomized clinical trial of hospital-based rehabilitation versus specialized assertive intervention (OPUS) versus standard treatment for patients with first-episode schizophrenia spectrum disorders.

M Nordentoft1, J Øhlenschlaeger, A Thorup, L Petersen, Pia Jeppesen, M Bertelsen.   

Abstract

BACKGROUND: The effects of hospital-based rehabilitation including weekly supportive psychodynamic therapy compared with specialized assertive intervention and standard treatment has not previously been investigated in first-episode psychosis. The aim of the study was to examine long-term effect on use of institutional care of different intensive interventions for patients with first-episode schizophrenia spectrum disorder on use of psychiatric bed days and days in supported housing.
METHOD: A total of 94 severely ill patients with first-episode schizophrenia spectrum disorders were included in a special part of the Copenhagen OPUS trial and randomized to either the specialized assertive intervention program (OPUS), standard treatment or hospital-based rehabilitation.
RESULTS: It was a stable pattern that patients randomized to hospital-based rehabilitation spent more days in psychiatric wards and in supported housing throughout the 5-year follow-up period compared with the two other groups. Patients in OPUS treatment spent significantly fewer days in psychiatric wards and supported housing in the first 3 years compared with patients in hospital-based rehabilitation. Due to attrition and small sample size, differences in level of psychotic and negative symptoms at 5-year follow-up could not be evaluated.
CONCLUSIONS: The study indicates that hospital-based rehabilitation together with weekly supportive psychodynamic therapy was associated with a continued increased use of psychiatric bed days and days in supported housing. The data cannot justify using hospital-based rehabilitation in first-episode psychosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20059798     DOI: 10.1017/S0033291709992182

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  7 in total

1.  Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study.

Authors:  C Morgan; J Lappin; M Heslin; K Donoghue; B Lomas; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; G A Doody; P Dazzan
Journal:  Psychol Med       Date:  2014-02-26       Impact factor: 7.723

2.  Burden of informal care giving to patients with psychoses: a descriptive and methodological study.

Authors:  Lena Flyckt; Anna Löthman; Leif Jörgensen; Anders Rylander; Thomas Koernig
Journal:  Int J Soc Psychiatry       Date:  2011-11-17

3.  Interventions for prodromal stage of psychosis.

Authors:  Dina Bosnjak Kuharic; Ivana Kekin; Joanne Hew; Martina Rojnic Kuzman; Livia Puljak
Journal:  Cochrane Database Syst Rev       Date:  2019-11-01

4.  Specialised early intervention teams for recent-onset psychosis.

Authors:  Stephen Puntis; Amedeo Minichino; Franco De Crescenzo; Andrea Cipriani; Belinda Lennox; Rachael Harrison
Journal:  Cochrane Database Syst Rev       Date:  2020-11-02

5.  Specialised early intervention teams (extended time) for recent-onset psychosis.

Authors:  Stephen Puntis; Amedeo Minichino; Franco De Crescenzo; Andrea Cipriani; Belinda Lennox; Rachael Harrison
Journal:  Cochrane Database Syst Rev       Date:  2020-11-02

6.  Integrated treatment vs. treatment-as-usual for recent onset schizophrenia; 12 year follow-up on a randomized controlled trial.

Authors:  Víðir Sigrúnarson; Rolf W Gråwe; Gunnar Morken
Journal:  BMC Psychiatry       Date:  2013-07-30       Impact factor: 3.630

7.  The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trial.

Authors:  Til Wykes; Eileen Joyce; Tjasa Velikonja; Andrew Watson; Gregory Aarons; Max Birchwood; Matteo Cella; Sue Dopson; David Fowler; Kathy Greenwood; Sonia Johnson; Paul McCrone; Jesus Perez; Andrew Pickles; Clare Reeder; Diana Rose; Swaran Singh; Dominic Stringer; Matthew Taylor; Rumina Taylor; Rachel Upthegrove
Journal:  Trials       Date:  2018-03-15       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.